Science Explorer Interactive view Map
Company · Madrid · Spain

PharmaMar (Spain)

In research, PharmaMar (Spain) stands highest in Medicine (#15,987 of 17,978 worldwide), Life Sciences (#12,768 of 14,347 worldwide) and Health Sciences (#18,904 of 20,462 worldwide), over all time.

World rank, all time
#27,925
of 42,892
Rank in Spain
#663
of 927
Research works
337
▼ 42% vs 2013–17
Citations
8.9k
26.3 per fractional work
Top-10% rate
9.4%
record average 16.5%
Open access
30%
world 28%

What is PharmaMar (Spain) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #15,987 of 17,978 12.9%128
Life SciencesDomain #12,768 of 14,347 12.1%156
Health SciencesDomain #18,904 of 20,462 13.1%130
Biochemistry, Genetics and Molecular BiologyField #7,594 of 7,814 12.6%135

Each strip is that field’s whole ranked pool, with the notch where PharmaMar (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.30× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.05× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.17× its world share, 1 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.40× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.89× its world share, 2 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.16× its world share, 0 worksEarth and Planetary …Energy: 0.12× its world share, 0 worksEnergyEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 0.83× its world share, 0 worksMathematicsPhysics and Astronomy: 0.15× its world share, 0 worksPhysics and AstronomyMedicine: 3.11× its world share, 20 worksMedicineVeterinary: 1.19× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.61× its world share, 0 worksEconomics, Econometr…Psychology: 0.32× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.4×. Every wedge is a field page.

Who are the top researchers at PharmaMar (Spain)?

Ranked on the composite score, Carlos M. Galmarini, José Jimeno and Pablo Avilés lead among researchers whose main affiliation is PharmaMar (Spain).

  1. 1 Carlos M. Galmarini Spain · #84,547 worldwide 229 citations · 40 works
  2. 2 José Jimeno Spain · #671,381 worldwide 51 citations · 24 works
  3. 3 Pablo Avilés Spain · #854,533 worldwide 16 citations · 19 works
  4. 4 Antonio Martínez Nieto Spain · #1,003,272 worldwide 2 citations · 66 works
  5. 5 Pilar Lardelli Spain · #1,070,538 worldwide 32 citations · 17 works
  6. 6 Carmen Cuevas Spain · #1,168,225 worldwide 47 citations · 30 works
  7. 7 María José Guillén Spain · #1,191,369 worldwide 8 citations · 17 works
  8. 8 Juan Fernando Martínez-Leal Spain · #1,256,159 worldwide 20 citations · 16 works
  9. 9 Carmen Kahatt Spain · #1,451,281 worldwide 23 citations · 24 works
  10. 10 Rogelio Fernández Spain · #1,543,905 worldwide 10 citations · 28 works
All ranked researchers at PharmaMar (Spain)

Which keywords describe research at PharmaMar (Spain)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, Biomarkers, Prognostic Factors, Metastasis and Genomic Profiles.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Chemotherapy6▲ 27×10 topics
  2. Clinical Trials6▲ 24×7 topics
  3. Immunotherapy5▲ 19×8 topics
  4. Targeted Therapy5▲ 61×4 topics
  5. Biomarkers4▲ 18×10 topics
  6. Prognostic Factors4▲ 25×5 topics
  7. Metastasis3▲ 30×4 topics
  8. Genomic Profiles3▲ 194×1 topic
  9. Small-Cell Lung Cancer3▲ 194×1 topic
  10. Cancer Therapy3▲ 14×9 topics
  11. Drug Discovery2▲ 33×3 topics
  12. Marine Natural Products2▲ 169×2 topics
  13. Genomic Profiling2▲ 62×2 topics
  14. Cancer2▲ 4.0×13 topics
  15. Genetic Mutations2▲ 12×5 topics
  16. Genome Sequencing2▲ 34×2 topics
  17. Natural Products2▲ 35×1 topic
  18. Secondary Metabolites2▲ 68×1 topic
  19. ALK Inhibitors2▲ 79×1 topic
  20. EGFR Mutations2▲ 79×1 topic
  21. Inflammation2▲ 2.4×11 topics
  22. DNA1▲ 228×1 topic
  23. Pharmacology1▲ 17×5 topics
  24. Topoisomerases1▲ 228×1 topic
  25. Tumor Microenvironment1▲ 9.4×6 topics
  26. Hematological Malignancies1▲ 97×2 topics
  27. Anticancer Agents1▲ 22×4 topics
  28. Metabolic Syndrome1▲ 3.9×5 topics
  29. Survival Analysis1▲ 11×2 topics
  30. Inappropriate Medication Use1▲ 68×1 topic
  31. Medicinal Chemistry1▲ 11×2 topics
  32. Neuroendocrine Tumors1▲ 90×1 topic
  33. PET Imaging1▲ 18×4 topics
  34. Pancreatic Neuroendocrine Tumors1▲ 90×1 topic
  35. Polypharmacy1▲ 68×1 topic
  36. Precision Medicine1▲ 6.3×5 topics

Which research topics does PharmaMar (Spain) publish most on?

By volume in 2022–2025: Lung Cancer Research Studies, Microbial Natural Products and Biosynthesis, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.

  1. 1 Lung Cancer Research Studies Oncology 3 works
  2. 2 Microbial Natural Products and Biosynthesis Pharmacology 2 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  4. 4 Cancer therapeutics and mechanisms Molecular Biology 1 works
  5. 5 Neuroendocrine Tumor Research Advances Epidemiology 1 works
  6. 6 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
  7. 7 Peptidase Inhibition and Analysis Oncology 1 works
  8. 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  9. 9 Synthesis and biological activity Organic Chemistry 1 works
  10. 10 Neutropenia and Cancer Infections Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 28% of research is openly available.

with international co-authors36.4%domestic only63.6%

World: 19% is written across borders.

How has PharmaMar (Spain)'s research output changed?

Output in 2018–2022 was 42% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madrid

All research institutions in Madrid

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.